Standout Papers

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the... 2011 2026 2016 2021 472
  1. Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study (2011)
    Owen A. O’Connor, Barbara Pro et al. Journal of Clinical Oncology
  2. Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy (2012)
    Bertrand Coiffier, Barbara Pro et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 11 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
Antisense oligonucleotide therapeutic approach for Timothy syndrome
2024 StandoutNature
8 intermediate papers

Works of Lauren Pinter‐Brown being referenced

Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
2020
Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients
2017
and 4 more

Author Peers

Author Last Decade Papers Cites
Lauren Pinter‐Brown 1916 1304 1183 97 3.2k
Kevin E. Salhany 1671 1016 1035 56 2.9k
Claudio Agostinelli 1910 1441 532 147 3.2k
Eric D. Jacobsen 2544 1885 726 145 4.4k
Harald Stein 1855 1441 461 53 3.9k
Santiago Montes‐Moreno 1876 1388 523 100 2.9k
Ryan A. Wilcox 1331 1972 946 122 4.2k
Jasmine Zain 2105 1609 1350 181 4.2k
Giovanna Roncador 2394 2246 664 99 5.9k
Joost J. Oudejans 1266 1334 303 68 3.0k
Kennosuke Karube 1713 1232 419 134 3.1k

All Works

Loading papers...

Rankless by CCL
2026